Xtl Biopharmaceuticals Ltd Stock Market Value
XTLB Stock | USD 2.10 0.22 11.70% |
Symbol | XTL |
XTL Biopharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.03) | Return On Assets (0.14) | Return On Equity (0.13) |
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
XTL Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XTL Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XTL Biopharmaceutica.
12/03/2023 |
| 12/27/2024 |
If you would invest 0.00 in XTL Biopharmaceutica on December 3, 2023 and sell it all today you would earn a total of 0.00 from holding XTL Biopharmaceuticals Ltd or generate 0.0% return on investment in XTL Biopharmaceutica over 390 days. XTL Biopharmaceutica is related to or competes with Benitec Biopharma, Xenetic Biosciences, ProPhase Labs, and BOS Better. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical p... More
XTL Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XTL Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XTL Biopharmaceuticals Ltd upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 7.1 | |||
Information Ratio | 7.0E-4 | |||
Maximum Drawdown | 45.84 | |||
Value At Risk | (9.55) | |||
Potential Upside | 11.7 |
XTL Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XTL Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XTL Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use XTL Biopharmaceutica historical prices to predict the future XTL Biopharmaceutica's volatility.Risk Adjusted Performance | 0.015 | |||
Jensen Alpha | (0) | |||
Total Risk Alpha | (0.37) | |||
Sortino Ratio | 7.0E-4 | |||
Treynor Ratio | 0.0405 |
XTL Biopharmaceuticals Backtested Returns
At this point, XTL Biopharmaceutica is extremely dangerous. XTL Biopharmaceuticals shows Sharpe Ratio of 0.0105, which attests that the company had a 0.0105% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for XTL Biopharmaceuticals, which you can use to evaluate the volatility of the company. Please check out XTL Biopharmaceutica's Mean Deviation of 4.88, risk adjusted performance of 0.015, and Downside Deviation of 7.1 to validate if the risk estimate we provide is consistent with the expected return of 0.0822%. The firm maintains a market beta of 1.2, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XTL Biopharmaceutica will likely underperform. XTL Biopharmaceuticals presently maintains a risk of 7.83%. Please check out XTL Biopharmaceuticals semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if XTL Biopharmaceuticals will be following its historical returns.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
XTL Biopharmaceuticals Ltd has almost perfect reverse predictability. Overlapping area represents the amount of predictability between XTL Biopharmaceutica time series from 3rd of December 2023 to 15th of June 2024 and 15th of June 2024 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XTL Biopharmaceuticals price movement. The serial correlation of -0.76 indicates that around 76.0% of current XTL Biopharmaceutica price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.76 | |
Spearman Rank Test | -0.35 | |
Residual Average | 0.0 | |
Price Variance | 0.16 |
XTL Biopharmaceuticals lagged returns against current returns
Autocorrelation, which is XTL Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XTL Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of XTL Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that XTL Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
XTL Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XTL Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XTL Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XTL Biopharmaceutica stock over time.
Current vs Lagged Prices |
Timeline |
XTL Biopharmaceutica Lagged Returns
When evaluating XTL Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XTL Biopharmaceutica stock have on its future price. XTL Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XTL Biopharmaceutica autocorrelation shows the relationship between XTL Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in XTL Biopharmaceuticals Ltd.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:Check out XTL Biopharmaceutica Correlation, XTL Biopharmaceutica Volatility and XTL Biopharmaceutica Alpha and Beta module to complement your research on XTL Biopharmaceutica. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.